VDP Stock Overview
Produces and sells pharmaceutical products under the Vidipha brand. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Vidipha Central Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫34,950.00 |
| 52 Week High | ₫40,800.00 |
| 52 Week Low | ₫31,083.33 |
| Beta | 0 |
| 1 Month Change | -0.71% |
| 3 Month Change | 3.71% |
| 1 Year Change | 7.54% |
| 3 Year Change | 9.79% |
| 5 Year Change | 35.73% |
| Change since IPO | 23.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| VDP | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | -2.9% | 1.1% | 0.8% |
| 1Y | 7.5% | 25.0% | 5.6% |
Return vs Industry: VDP underperformed the VN Pharmaceuticals industry which returned 25% over the past year.
Return vs Market: VDP exceeded the VN Market which returned 5.6% over the past year.
Price Volatility
| VDP volatility | |
|---|---|
| VDP Average Weekly Movement | 6.2% |
| Pharmaceuticals Industry Average Movement | 4.4% |
| Market Average Movement | 3.8% |
| 10% most volatile stocks in VN Market | 7.4% |
| 10% least volatile stocks in VN Market | 2.2% |
Stable Share Price: VDP's share price has been volatile over the past 3 months compared to the VN market.
Volatility Over Time: VDP's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of VN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Hoa Van Hoang | www.vidipha.com.vn |
Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products under the Vidipha brand. The company primarily provides antibiotics, anti-inflammatory, vitamins and mineral salts, pain relievers, antipyretics, anti-allergy drugs, and other medicines for the treatment of worm, fluke, respiratory, gastrointestinal, and skin diseases. It offers its products in the form of compress and capsule Pills, Powdered granules, powder and liquid Injections, Syrups, drinking tubes, Eye and nose drops, Topical creams, and ointments.
Vidipha Central Pharmaceutical Joint Stock Company Fundamentals Summary
| VDP fundamental statistics | |
|---|---|
| Market cap | ₫771.82b |
| Earnings (TTM) | ₫0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs VDP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VDP income statement (TTM) | |
|---|---|
| Revenue | ₫0 |
| Cost of Revenue | ₫0 |
| Gross Profit | ₫0 |
| Other Expenses | ₫0 |
| Earnings | ₫0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did VDP perform over the long term?
See historical performance and comparisonDividends
6.4%
Current Dividend Yieldn/a
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/07 01:42 |
| End of Day Share Price | 2025/02/07 00:00 |
| Earnings | N/A |
| Annual Earnings | N/A |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vidipha Central Pharmaceutical Joint Stock Company is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hang Thi Ha | Bao Viet Securities Joint Stock Company |